share_log

Safety Shot | CORRESP: CORRESP

Safety Shot | CORRESP: CORRESP

Safety Shot | CORRESP:信函
美股SEC公告 ·  02/05 14:00

Moomoo AI 已提取核心訊息

Safety Shot, Inc. has submitted a response to the Securities and Exchange Commission (SEC) addressing comments from the SEC's letter dated February 1, 2024, regarding Post-Effective Amendment No. 5 on Form S-1 filed on January 23, 2024. The company clarified discrepancies in its disclosures, particularly around the classification and regulatory requirements of its products, including JW-500, JW-700, Photocil, and Safety Shot Beverage. Safety Shot, Inc. has updated its Registration Statement to reflect these clarifications and to remove any statements of safety and efficacy for products not approved by the FDA or similar foreign regulators. The company also provided additional information on the commercialization status of its products, including the markets where they are sold and their development stages. Furthermore, Safety Shot, Inc. outlined...Show More
Safety Shot, Inc. has submitted a response to the Securities and Exchange Commission (SEC) addressing comments from the SEC's letter dated February 1, 2024, regarding Post-Effective Amendment No. 5 on Form S-1 filed on January 23, 2024. The company clarified discrepancies in its disclosures, particularly around the classification and regulatory requirements of its products, including JW-500, JW-700, Photocil, and Safety Shot Beverage. Safety Shot, Inc. has updated its Registration Statement to reflect these clarifications and to remove any statements of safety and efficacy for products not approved by the FDA or similar foreign regulators. The company also provided additional information on the commercialization status of its products, including the markets where they are sold and their development stages. Furthermore, Safety Shot, Inc. outlined the regulatory categories for its products under FDA guidelines, specifying that Photocil, JW-500, and JW-700 are classified as cosmetic products, while Safety Shot Beverage is classified as a dietary supplement. The company also addressed a lawsuit involving GBB Lab, Inc., a subsidiary formed to acquire assets related to the Safety Shot Beverage, stating that the outcome of the litigation is not material to the company's business. The response included a request for a call with the SEC to ensure all comments have been satisfactorily addressed.
Safety Shot, Inc.已向美國證券交易委員會(SEC)提交了回應,回應了美國證券交易委員會(SEC)於2024年2月1日就2024年1月23日提交的S-1表格生效後第5號修正案的信函中的評論。該公司澄清了其披露中的差異,特別是圍繞其產品(包括 JW-500、JW-700、Photocil 和安全注射飲料)的分類和監管要求方面的差異。Safety Shot, Inc. 已更新其註冊聲明,以反映這些澄清,並刪除了未經美國食品藥品管理局或類似外國監管機構批准的產品的任何安全性和有效性聲明。該公司還提供了有關其產品商業化狀況的更多信息,包括其銷售的市場及其開發階段。此外,Safety Sh...展開全部
Safety Shot, Inc.已向美國證券交易委員會(SEC)提交了回應,回應了美國證券交易委員會(SEC)於2024年2月1日就2024年1月23日提交的S-1表格生效後第5號修正案的信函中的評論。該公司澄清了其披露中的差異,特別是圍繞其產品(包括 JW-500、JW-700、Photocil 和安全注射飲料)的分類和監管要求方面的差異。Safety Shot, Inc. 已更新其註冊聲明,以反映這些澄清,並刪除了未經美國食品藥品管理局或類似外國監管機構批准的產品的任何安全性和有效性聲明。該公司還提供了有關其產品商業化狀況的更多信息,包括其銷售的市場及其開發階段。此外,Safety Shot, Inc.根據美國食品藥品管理局的指導方針,概述了其產品的監管類別,規定Photocil、JW-500 和 JW-700 被歸類爲化妝品,而安全射擊飲料被歸類爲膳食補充劑。該公司還處理了涉及GBB Lab, Inc. 的訴訟,該公司是一家爲收購與Safety Shot Beverage相關的資產而成立的子公司,稱訴訟結果對公司的業務無關緊要。回應包括要求與美國證券交易委員會通話,以確保所有評論都得到令人滿意的處理。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息